The advanced therapeutics pharmaceutical outsourcing market is projected to grow from USD 7,514.5 million in 2025 to USD 11,558.6 million by 2035, at a CAGR of 4.4%. Contract Research Organizations (CROs) will dominate with a 57.6% market share, while oncology will lead the indication segment with a 34.2% share.